Astellas is to work with UK biotech Adaptimmune Therapeutics to develop allogeneic ‘off-the-shelf’ T-cell therapies for cancer. The Japanese pharma said its wholly-owned subsidiary Universal ...
Astellas’ regulatory affairs function plays ... and head of the Regulatory Affairs function worldwide and is based in Leiden in the Netherlands. In this role Stef is a member of the Medical ...
NORTHBROOK, Ill., Feb. 27, 2025 /PRNewswire/ -- Astellas Pharma U.S. Inc. (Head of Commercial: Mike Petroutsas, "Astellas"), and MBC BioLabs, a premier launchpad for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback